Henry Schein (NASDAQ:HSIC) Upgraded by BMO Capital Markets to Hold Rating

BMO Capital Markets upgraded shares of Henry Schein (NASDAQ:HSIC) to a hold rating in a report issued on Wednesday,Zacks.com reports.

Several other research firms also recently commented on HSIC. UBS Group reaffirmed a “neutral” rating and issued a $85.00 price objective (down from $87.00) on shares of Henry Schein in a research note on Wednesday, May 6th. BTIG Research raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research note on Thursday, June 11th. Robert W. Baird set a $97.00 price target on shares of Henry Schein in a research note on Wednesday, May 6th. Weiss Ratings reissued a “hold (c+)” rating on shares of Henry Schein in a report on Monday, May 4th. Finally, Mizuho reduced their target price on Henry Schein from $88.00 to $82.00 and set a “neutral” rating on the stock in a report on Wednesday, May 6th. Seven equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $87.64.

Henry Schein Stock Up 0.8%

Shares of Henry Schein stock opened at $83.86 on Wednesday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.75 and a current ratio of 1.36. The stock has a market capitalization of $9.55 billion, a PE ratio of 25.34, a price-to-earnings-growth ratio of 1.60 and a beta of 0.81. Henry Schein has a 52-week low of $61.94 and a 52-week high of $89.29. The company has a 50-day simple moving average of $77.83 and a two-hundred day simple moving average of $77.29.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.32 EPS for the quarter, beating analysts’ consensus estimates of $1.20 by $0.12. The firm had revenue of $3.37 billion for the quarter, compared to analysts’ expectations of $3.34 billion. Henry Schein had a net margin of 2.95% and a return on equity of 15.44%. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.15 earnings per share. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. On average, analysts anticipate that Henry Schein will post 5.32 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director William K. Daniel purchased 10,000 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The stock was bought at an average price of $69.19 per share, for a total transaction of $691,900.00. Following the completion of the transaction, the director owned 20,000 shares in the company, valued at approximately $1,383,800. The trade was a 100.00% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 0.89% of the company’s stock.

Institutional Trading of Henry Schein

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Invesco Ltd. increased its position in Henry Schein by 4.1% during the third quarter. Invesco Ltd. now owns 4,731,698 shares of the company’s stock valued at $314,043,000 after acquiring an additional 184,763 shares during the last quarter. Southpoint Capital Advisors LP boosted its stake in shares of Henry Schein by 28.0% during the 1st quarter. Southpoint Capital Advisors LP now owns 3,200,000 shares of the company’s stock worth $235,840,000 after purchasing an additional 700,000 shares during the period. Dimensional Fund Advisors LP boosted its stake in shares of Henry Schein by 2.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,873,004 shares of the company’s stock worth $211,734,000 after purchasing an additional 56,687 shares during the period. Ameriprise Financial Inc. raised its position in Henry Schein by 11.3% in the 3rd quarter. Ameriprise Financial Inc. now owns 2,523,014 shares of the company’s stock worth $167,453,000 after purchasing an additional 256,156 shares during the period. Finally, Bank of Montreal Can lifted its stake in Henry Schein by 3,655.7% in the fourth quarter. Bank of Montreal Can now owns 2,144,773 shares of the company’s stock worth $162,102,000 after purchasing an additional 2,087,666 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.